Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Alphavirus-based vaccine encoding PSA tested in mouse model of prostate cancer

Dec. 4, 2013

FDA clears California Stem Cell's application for phase III cancer stem cell trial

Dec. 4, 2013

Celldex Therapeutics initiates study of glembatumumab vedotin for triple-negative breast cancer

Dec. 4, 2013

Immunotherapeutic 3M-052 shows oncolytic potential

Dec. 3, 2013

ARMO BioSciences begins phase I study of AM-0100 in advanced solid tumors

Nov. 29, 2013

Immatics presents preliminary phase I results for the novel cancer vaccine IMA-950

Nov. 29, 2013

SillaJen to acquire Jennerex

Nov. 29, 2013

Genmab reaches milestone in Janssen Biotech collaboration

Nov. 27, 2013

Lytix Biopharma enrolls first patient in study of LTX-315

Nov. 27, 2013

E39 is well tolerated in patients with endometrial and ovarian cancer

Nov. 27, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 9, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...